GO
Loading...

Novartis will remain under pressure: pro

Wednesday, 17 Jul 2013 | 3:30 AM ET

Andrew Weiss, head of pharma and biotech research at Vontobel, , talks about Novartis' quarterly results and outlook and says the company will remain under pressure for the next few quarters.